Track Nano-X Imaging Ltd. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Nano-X Imaging Ltd. NNOX Open Nano-X Imaging Ltd. in new tab

1.70 USD
EPS
-1.16
P/B
0.85
ROE
-45.62
Beta
1.18
Target Price
6.65 USD
Nano-X Imaging Ltd. logo

Nano-X Imaging Ltd.

🧾 Earnings Recap – Q3 2025

Nano-X Imaging Ltd. delivered solid progress in Q3 2025, outlining a strategic roadmap for growth while positioning itself for over $35 million in revenues for 2026.

  • Expanded agreements in Europe signal strong demand for Nano-X ARC and reinforce its European strategy.
  • Launch of the next-generation Nano-X ArcX system is set to enhance market reach and adaptability, including AI compatibility.
  • Acquisition of Vaso Healthcare IT bolsters Nano-X's capabilities in integrating imaging AI, enriching its service offering and market potential.
  • Progress in operational efficiency and production capabilities ensures a solid foundation for sustainable growth moving forward.
📅
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateJuly 20, 2026
EPS-1.16
Book Value2.01
Price to Book0.85
Debt/Equity5.62
% Insiders0.346%
Growth
Revenue Growth0.24%
Estimates
Forward P/E-34.18
Forward EPS-0.05
Target Mean Price6.65

DCF Valuation

Tweak assumptions to recompute fair value for Nano-X Imaging Ltd. (NNOX)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Nano-X Imaging Ltd. Logo Nano-X Imaging Ltd. Analysis (NNOX)

Israel Health Care Official Website Stock

Is Nano-X Imaging Ltd. a good investment? Nano-X Imaging Ltd. (NNOX) is currently trading at 1.70 USD. Market analysts have a consensus price target of 6.65 USD. This suggests a potential upside from current levels.

Earnings Schedule: Nano-X Imaging Ltd. is expected to release its next earnings report on July 20, 2026. The market consensus estimate for Forward EPS is -0.05.

Investor FAQ

Does Nano-X Imaging Ltd. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Nano-X Imaging Ltd.?

Nano-X Imaging Ltd. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be July 20, 2026. The company currently has a trailing EPS of -1.16.

Company Profile

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists; Nanox.CONNECT to receive local regulatory approvals and explore and evaluate the business model and the potential service; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data of existing computed tomography scans; and Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers and mobile imaging service providers, urgent care facilities, and multi-specialty physician groups. In addition, the company provides Real+ Osteoporosis Care Management Platform, a osteoporosis care management software platform; AI-Based Aortic Valve Calcification Measurement, an artificial intelligence–based solution; AI-Based Body Composition Measurement, an artificial intelligence–based body composition analysis capability; and Nanox Health IT, a healthcare information technology services provider that serves hospitals and other healthcare organizations. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Petah Tikva, Israel.

Exchange Ticker
NGM (Sweden) NNOX

Dividends

Historical Split Corporate Actions

Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion